Brief Article
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2014; 20(1): 235-241
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.235
Table 1 Patients’ general characteristics n (%)
Numbers
Age (range), yr531 (36-71)
Sex
Male25 (81)
Female6 (19)
Etiology
HBV26 (83.9)
HCV1 (3.2)
Others4 (12.9)
Status of primary liver mass
Stable13 (41.9)
Progressive18 (58.1)
Metastatic sites
Lung28 (90.3)
Lymph node10 (32.3)
Bone8 (25.1)
Peritoneum3 (9.7)
Previous treatment before sorafenib
TACE29 (93.5)
Surgery17 (54.8)
Radiation12 (38.7)
Hepatic arterial infusion9 (29.0)
Radiofrequency ablation5 (16.1)